Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Aug 19;15(8):e0237726. doi: 10.1371/journal.pone.0237726

Effects of microsurface structure of bioactive nanoparticles on dentinal tubules as a dentin desensitizer

Yang-Jung Choi 1, Moon-Kyoung Bae 2, Yong-Il Kim 3, Jeong-Kil Park 1, Sung-Ae Son 1,*
Editor: Hamid Reza Bakhsheshi-Rad4
PMCID: PMC7437925  PMID: 32813737

Abstract

In this in vitro study, spherical mesoporous bioactive glass nanoparticle (MBGN) and non-porous bioactive glass nanoparticle (BGN) were fabricated. The impact of mesopores on dentinal tubule occlusion and bioactivity was compared to examine the potential of these materials in alleviating dentine hypersensitivity (DH). MBGN, dense BGN were synthesized by sol-gel methods and characterized. Bioactivity and ion dissolution ability were analyzed. Twenty-four simulated sensitive dentin discs were prepared and randomly divided into three groups (n = 8 each); Group 1, no treatment; Group 2, Dense BGN; Group 3, MBGN. Then, four discs per group were treated with 6wt.% citric acid challenge to determine the acidic resistance. The effects on dentinal tubule occlusion were observed by FESEM. The microtensile bond strength (MTBS) was also measured. Cytotoxicity was examined using the MTT assay. According to the results, dense BGN without mesopore and MBGN with mesopore were successfully fabricated. Dense BGN and MBGN occluded the dentinal tubule before and after acid challenge. However, only MBGN formed a membrane-like layer and showed hydroxyapatite formation after soaking SBF solution. There were no significant differences in MTBS among dense BGN, MBGN (P>0.05). The cell viability was above 72% of both materials. The higher bioactivity of MBGN compared with that of dense BGN arises from the structural difference and it is anticipated to facilitate dentin remineralization by inducing hydroxyapatite deposition within the dentinal tubule.

1. Introduction

Dentin hypersensitivity (DH) generally occurs upon external stimulation from steam, heat, and contact with the dentinal tubule that is exposed as a result of gingival recession or enamel loss caused by abrasion, attrition, or acid erosion [1]. The incidence of DH ranges from 10–30% and commonly affects women in their 20s–50s. DH frequently occurs in canines and first premolars and is characterized by momentary and sharp pain upon external stimulation [2]. Among various theories pertaining to the etiology of DH, the most widely accepted theory is the hydrodynamic theory. Proposed by Brannstrom and Astrom, the hydrodynamic theory posits that thermal, osmotic, and physical stimuli induce movement of fluid within the dentinal tubule and stimulate the nerve endings. Such nerve ending activation is known to cause sharp, rapid pain, and many treatments primarily aim to occlude the dentinal tubule to prevent this activation [3, 4].

Products that alleviate DH include calcium-containing gum, toothpaste, mouthwash, and professional fluoride varnish, but their effects are transient, and the products need to be repeatedly applied [5]. Recently, a remineralization solution containing potassium oxalate and ferric oxalate was introduced, and it has been confirmed to mitigate DH by occluding exposed dentinal tubules. However, the limitation of the short duration of the occluding effect remains [69]. Furthermore, dentinal tubules were found to be re-exposed upon exposure to dietary acid [10, 11]. Therefore, biomaterials used to treat DH must have practical occluding effects for dentinal tubules and have long-term stability even after exposure to dietary acid [12, 13]. In general, DH is accompanied by hard tissue defects. Such cases require additional resin restoration, and the desensitizing treatment must not have a negative impact on the bond strength between the restoration material and teeth [14].

Bioactive glass nanoparticles (BGN) show large surface area, high intensity of illumination, hydrophilicity, and wettability while having cell adhesive capacities and high bioactivity in host tissue [15, 16]. Once BGN powder comes into contact with a biological fluid, such as saliva, it releases sodium and calcium ions and increases pH, thereby creating an alkaline environment [17]. In an alkaline environment, calcium and phosphate ions form an apatite that occludes the dentinal tubule and diminishes fluid movement within the dentinal tubule [18]. Recent studies reported successful dentinal tubule occlusion and dentin remineralization using BGN. Besinis et al. [19] applied bioactive hydroxyapatite (HA) and silica nanoparticles on dental specimens and confirmed that they infiltrate the dentinal tubule and cause remineralization in the dental specimens.

Mesoporous bioactive glass (MBG) is a bioactive glass (BG), with 2–50 nm mesopores, that has a larger surface area compared to non-porous BG. Owing to such features, it has a relatively higher response rate, dissolution capacity, and property to induce re-precipitation of apatite materials [20, 21]. Moreover, a recent study reported that MBG has better biocompatibility than BG [17]. In a comparison of the bioactivities of MBG and BG scaffolds, Zhu et al. [22] reported that calcium and phosphate ions aggregate and form nucleation on the surface of MBG better than on BG and MBG is, therefore, associated with quicker crystallization and better bone-forming bioactivity. Considering the size of dentinal tubules near enamels, applying nanosized particles to dentinal tubules appears to have increased the dentinal tubule-occluding effects. In 2019, Yuan et al. [23] confirmed that applying nanosized HA particles to dentinal tubules increases the proportion of dentinal tubule occlusion. However, studies that compare the dentinal tubule-occluding capacity and bioactivity of mesoporous bioactive glass nanoparticles (MBGN) and non-porous BGN are rare. In this context, this study aims to synthesize spherical MBGN and non-porous BGN and compare the impact of mesopores on dentinal tubule occlusion and bioactivity to examine the potential of these materials in alleviating DH.

2. Materials and methods

Dense BGN and MBGN was synthesized by sol-gel method and characterized by X-ray diffraction (XRD), Fourier transform infrared (FT-IR) spectroscopy, N2 adsorption-desorption isotherms, field-emission scanning electron microscopy (FESEM). In vitro bioactivity, ion dissolution ability, dentinal tubule occlusion ability, effect on microtensile strength of composite resin material and cytotoxicity of both bioactive glasses were evaluated (Fig 1).

Fig 1. A schematic diagram of materials and method.

Fig 1

2.1 Synthesis of bioactive glass

2.1.1. Synthesis of dense bioactive glass nanoparticles and mesoporous bioactive glass nanoparticles

Dense BGN was synthesized using the sol-gel method (Fig 2A). A solution containing 5 ml tetraethyl orthosilicate (TEOS) (Sigma-Aldrich, St. Louis, MO, USA) and 0.25 ml triethyl phosphate (TEP) (Sigma-Aldrich, St. Louis, MO, USA) in 50 ml ethanol (Samchun, Pyeongtaek, South Korea) was added to a solution consisting of 16.24 ml ethanol and ammonium hydroxide solution (Samchun, Pyeongtaek, South Korea) and was continuously stirred for 35 minutes. After adding 3.12 g ground calcium nitrate tetrahydrate (Sigma-Aldrich, St. Louis, MO, USA) to this solution, it was vigorously stirred for 85 minutes. The solution was then centrifuged at 7,350 rpm for 5 minutes, washed with ethanol, dried at 60°C for 6 hours, and calcinated in a 600°C furnace for 5 hours.

Fig 2. An experimental visual form of bioactive glass nanoparticle by sol-gel method.

Fig 2

(a) Dense BGN, (b) MBGN.

MBGN was synthesized using the sol-gel synthesis protocol (Fig 2B). In a solution containing 150 ml water and 20 ml ethanol, 10 ml 2-ethoxyethanol (Sigma-Aldrich, St. Louis, MO, USA) was added as a co-solvent, and 1 g surfactant hexadecyltrimethylammonium bromide (CTAB) (Sigma-Aldrich, St. Louis, MO, USA), 2 ml catalyst aqueous ammonia (Samchun, Pyeongtaek, South Korea), and 3.12 g precursor calcium nitrate tetrahydrate were added and stirred for 30 minutes at room temperature. Subsequently, 5 ml TEOS was added to this solution and stirred for 30 minutes. After adding 0.25 ml triethyl phosphate to achieve a silicon dioxide to phosphate ratio of 60:4, the solution was vigorously stirred for 4 hours to obtain white precipitation and dried at 60°C for 24–48 hours. The precipitate was then calcinated in a 600°C furnace for 5 hours.

2.2. Materials characterizations

The synthesized dense BGN and MBGN were characterized as follows. The crystalline phase was determined via x-ray diffraction (XRD) analysis using 40 kV, 40 mA Cu-Kɑ radiation, and an X-ray diffractometer (Ultima IV multipurpose XRD system, Rigaku, The Woodland, TX, USA). XRD analysis was performed with a scanning speed of 4°/min and 2θ range of 10–70° for wide-angle XRD patterns, and with a scanning speed of 1.2°/min and range of 0.5–10° for small-angle XRD patterns. Functional groups and chemical composition were examined via Fourier-transform infrared spectroscopy (FTIR) analyses using a Nicolet 5700 spectrometer (Thermo Scientific Inc., Madison, WI, USA). Information about N2 adsorption-desorption isotherms was obtained at 77 K using an ASAP 2420 gas adsirotuib analyzer (Micromeritics, Atlanta, GA, USA). Specific surface area and pore size distribution were calculated via the BET and BJH method, respectively. The topography of the sample was observed and analyzed with field emission scanning electron microscopy (FESEM) (Sigma, Zeiss, Germany).

2.3. Ion dissolution test and in vitro bioactivity

Dense BGN and MBGN were placed in multiple channel pelleting molds, and 5 MPa pressure was applied for 60 seconds to produce 12 tablets of 10 mm diameter and 1 mm thickness. The mineralization experiment proceeded in compliance with the International standards (ISO/FDIS 23317). Stimulated body fluid 5X (SBF) (Biosesang, Seongnam, Korea) was prepared, and the SBF volume was calculated using the following formula:

Vs=Sa/10

where Vs is the volume of SBF solution (mL), and Sa is the surface of tablets (mm2).

After placing 19 mL SBF in the tube, tablets were inserted and stored at 36.5°C for 1, 3, 7, 14, and 42 days. Each tablet was then removed from the SBF solution, washed once with ethanol and twice with pure water to stop the mineralization process, and dried in an oven at 60°C. The mineral composition and crystal structure of the hydroxyapatite formed on the surface of the tablets were analyzed with XRD (Rigaku, The woodland, TX, USA) and Fourier-transform infrared spectroscopy (PerkinElmer Inc., Waltham, MA, USA). Hydroxyapatite formed on the surface of the tablets was observed with scanning electron microscopy (SEM). ICP-OES (Optima 8300, Perkin Elmer, Waltham, MA, USA) was performed on the SBF solution used to soak the tablets to analyze the dissolved ions.

2.4. Dentinal tubule occlusion test

2.4.1. Sample preparations and experimental design

Twenty-four premolars were collected in a manner that was verified and reviewed by the Institutional Review of Pusan National University Dental Hospital (PNUDH-2019-040). The teeth were stored in 4°C, 0.5% thymol solution, and were used within 3 months of extraction. A low-speed diamond saw (Struers Accutom-50, Ballerup, Denmark) was used to section each tooth from the inferior of the enamel-dentinal junction vertically to the long axis under water cooling to obtain 1 mm tooth discs. The discs were polished for 60 seconds using 320- and 600-grit silicon carbide (SiC) polishing paper. After soaking the discs in 1 wt.% citric acid solution for 20 seconds to open the dentinal tubules for the fabrication of sensitive tooth models, they were rinsed with water spray. The specimens were randomized into one of the following 3 groups (n = 8).

  • Group 1: No treatment (control).

  • Group 2: Slurry prepared with a ratio of 100 mg Dense BGN/200 μL deionized water is placed in a rubber cup installed on a NiTi engine (X Smart Plus, Dentsply Sirona, Ballaigues, Switzerland), run for 15 seconds at 800 rpm and again for a further 15 seconds, a total of 30 seconds.

  • Group 3: Slurry prepared with a ratio of 100 mg MBGN/200 μL deionized water is placed in a rubber cup installed on a NiTi engine, run for 15 seconds at 800 rpm, and again for a further 15 seconds, a total of 30 seconds.

To determine the resistance to a strong acidic environment, four discs from each group were randomly selected and post-treatment was applied to the remaining discs. Each disc was soaked in 6 wt.% citric acid solution (pH 1.5) for 60 seconds and wholly rinsed with deionized water.

2.4.2. FESEM evaluation of dentinal tubule occlusion

After fabricating tooth discs using the method previously described, treated samples were prepared, and the surfaces were observed with FESEM. After washing each disc with a water spray and drying, the discs were sputter-coated using Au-Pd alloy. Two areas of each sample were observed with FESEM at x2,000, x5,000, and x10,000 magnification to obtain micrographs. Image J (NIH, Frederick, MD, USA) was used to calculate the occluded dentinal tubule ratio (the area of occluded tubules/total tubules area). To compare the occluded dentinal tubule depths by group, a groove was formed on the additionally prepared tooth samples and then longitudinally sectioned to expose the longitudinal surface. After performing sputter-coating via the same method described previously, the samples were observed via FESEM at x10,000 magnification.

2.5. Microtensile bond strength (MTBS) test

To assess the impact of each desensitizing treatment on immediate MTBS, an additional 15 teeth were collected, and the mid-coronal surfaces of the teeth were exposed by sectioning them vertically to the long axis under water cooling using a low-speed diamond saw (Struers Accutom-50, Ballerup, Denmark). The exposed surface was polished with 600-grit SiC paper and soaked in 1 wt.% citric acid solution to reproduce the sensitive tooth model. The samples were randomized into one of 3 groups (n = 5) and treated accordingly as described in 2.4.1, washed with water spray for 30 seconds, and dried. Clearfil SE bond (Kuraray Co., Osaka, Japan) was applied to the surface of each sample as per the manufacturer’s instructions, and resin composite (Z250, 3M ESPE, St Paul, MN, USA) was applied in layers of 2 mm for a total thickness of 4 mm, followed by 20 seconds of photopolymerization using an LED curing unit (DEMI; > 1000mW/cm2; Kerr Corporation, Middleton, WI, USA). After storing them in deionized water at 37°C for 24 hours, the bonded teeth were sectioned to obtain 4 beam specimens, 0.9 mm x 0.9 mm, for each tooth, a total of 20 specimens. Each beam was fixed on an MTBS tester (Bisco, Schaumburg, IL, USA) using a cyanoacrylate adhesive and tensile force was applied at 1 mm/min crosshead speed until failure occurred.

2.6. Cytotoxicity assay

Human dental pulp tissues were obtained from premolars extracted for orthodontic purposes, and human dental pulp cells (HDPCs) were extracted. Separated pulp tissues were cultured in a ɑ-modified essential medium (Dulbecco’s modified Eagle’s medium; LM001-01; Welgene, Seoul, South Korea). After adding 10% fetal bovine serum (Gibco, CA, USA), 100 units/mL penicillin, and 100 mg/mL streptomycin to the medium, pulp tissues were incubated in a humidified atmosphere at 37°C and 5% CO2. The medium was replaced every two days, and third passage cells were used. In vitro cytotoxicity of dense BGN and MBGN was examined with 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. After applying dense BGN and MBGN (0, 10, 20, 40, 80, 160, 320 μg/mL distilled water (DW)) on a 48-well plate, the DW was evaporated. HDPCs were seeded at 10,000 cells/well and incubated at 37°C and 5% CO2 for 72 h. Subsequently, 5 mg/ml MTT (Sigma-Aldrich, St. Louis, MO, USA) was applied and incubated for 3 hours, followed by 5 minutes of washing with dimethyl sulfoxide (DMSO) (Sigma-Aldrich, St. Louis, MO, USA). The optical density was measured using the ELISA reader (Dynex, Chantilly, USA). This experiment was conducted in triplicate, and the results were presented as relative cell viability (%) against the control group for which only the culture medium was measured.

3. Results

3.1. Materials characterizations

3.1.1. XRD and FTIR

Fig 3 shows the XRD patterns of MBGN and dense BGN. In the wide-angle XRD patterns, neither MBGN nor dense BGN showed diffraction peaks other than the SiO2 peak near 2θ≈25°. In the small-angle XRD patterns, MBGN showed a peak near 2.5°. In contrast, dense BGN did not show diffraction peaks in the small-angle XRD patterns.

Fig 3.

Fig 3

(a) Wide-angle XRD pattern of MBGN and Dense BGN, (b) Small-angle XRD pattern of MBGN and Dense BGN.

Fig 4 shows the FTIR spectra of MBGN and dense BGN. Both MBGN and dense BGN show a silicate adsorption band in an asymmetric stretching mode near 1060, 800, and 470 cm-1.

Fig 4. FT-IR pattern of MBGN and Dense BGN.

Fig 4

3.1.2. Surface area and pore size análisis

The porosity of MBGN and dense BGN was evaluated using N2 adsorption-desorption isotherms. MBGN showed a type IV isotherm, while dense BGN showed a type II isotherm. In Fig 5, MBGN shows type H1 hysteresis loops. This suggests that pores of relatively equal size are evenly distributed. Table 1 shows the results of SBET (m2/g), Vp (cm3/g), and Dp (Å) of MBGN and dense BGN analyzed via the BET and BJH methods. MBGN had a markedly greater surface area (152.40 m2/g) than that of dense BGN (7.37 m2/g).

Fig 5. Nitrogen adsorption-desorption isotherms of MBGN and dense BGN.

Fig 5

Table 1. N2 adsorption results.
Samples SBET(m2/g) Vp(cm3/g) Dp(nm)
MBGN 152.40 0.15 3.99
Dense BGN 7.37 0.02 13.11

SBET(m2/g), surface area; Vp(cm3/g), total pore volume for pores with radius; Dp(nm), average pore radius.

3.1.3. FESEM images

The topology of the materials was analyzed using FESEM. On the FESEM image, MBN showed a size of 512–604 nm (Fig 6(A)), while dense BGN showed a size of 493–502 nm (Fig 6(B)). Whereas the surface of the BGN is irregular, that of the dense BGN is smooth.

Fig 6.

Fig 6

FESEM images of (a) MBGN and (b) Dense BGN.

3.2. Ion dissolution test

Ion dissolution of dense BGN and MBGN is shown in Fig 7. Calcium ion concentration decreased over time for both dense BGN and MBGN, with a more significant reduction in MBGN. In MBGN, calcium ion concentration decreased from 0.617 ppm to 0.078 ppm on 14 and 42 days, respectively, showing that it decreased to almost 0 ppm. Phosphate ion concentration increased over time. Dense BGN had a higher phosphate ion concentration than MBGN until 14 days, however after 42 days MBGN had a higher phosphate concentration. Silicon ion concentration gradually increased over time, with a more significant increase in dense BGN than in MBGN.

Fig 7. Change in calcium, phosphate, silicon concentration over time.

Fig 7

3.3. In vitro bioactivity study

3.3.1. XRD analysis and FTIR

Fig 8 shows a graph of the XRD patterns of MBGN and dense BGN soaked in SBF. In the pattern with the 2θ range set to 10°–60°, a SiO2 peak (amorphous phase) was observed. MBGN samples soaked in SBF solution for 5, 14, and 42 days showed a peak for the hydroxyapatite phase (HAp, Ca10 (PO4)6 (OH)2, JCPDS #09–0432), while dense BGN samples did not show this peak.

Fig 8.

Fig 8

X-ray diffraction patterns of (a) MBGN and (b) Dense BGN at 1, 3, 5, 7, 14, 42 days after soaking in simulated body fluid (SBF) solution.

Fig 9 shows a graph of FTIR patterns of MBGN and dense BGN samples soaked in SBF. The FTIR pattern of MBGN shows Si-O-Si asymmetric stretching and rocking vibration at 800 cm-1. Si-OH bonding-related vibration is observed at 1644, 957 cm-1, and CO32—related C-O peak (carbonated hydroxyapatite) is observed at 1428, 873 cm-1. In the FTIR patterns of dense BGN, Si-O-Si asymmetric stretching and rocking vibration at 800 cm-1 and Si-OH bonding-related vibration at 957 cm-1 was observed.

Fig 9.

Fig 9

FT-IR patterns of (a) MBGN and (b) Dense BGN at 1, 3, 5, 7, 14, 42 days after soaking in simulated body fluid (SBF) solution.

3.3.2. FESEM images

Fig 10 shows the results of FESEM images of tablet forms of MBGN and dense BGN precipitated for 1, 3, 5, 7, 14, and 42 days in the SBF solution. With MBGN samples, the FESEM image of the sample precipitated in the SBF solution for 42 days shows hydroxyapatite in a flake-like form. With dense BGN samples, hydroxyapatite formation was not observed in any of the images of the samples.

Fig 10.

Fig 10

FESEM images of (a) MBGN and (b) Dense BGN tablet at 1, 5, 42 days after soaking in simulated body fluid (SBF) solution.

3.4. Dentinal tubule occlusion test

3.4.1. FESEM observation of tubule occlusion

Fig 11 shows the FESEM images of the surfaces and longitudinal sections of the disc teeth samples simulating hypersensitive teeth. Group 1 (Fig 11A1–11D1 ) has a dentin surface with no smear layer as the dentinal tubule was opened after soaking in 1 wt.% citric acid solution for 20 seconds. Group 2 (Fig 11A2–11D2) and Group 3 (Fig 11A3–11D3) are groups that were treated with dense BGN and MBGN, respectively, and the images show that the particles partially occluded the dentinal tubules.

Fig 11.

Fig 11

FESEM micrographs of the top and longitudinal sections of the hypersensitive tooth model to confirm the tubule-occluding effect in each group (A, x2,000; B, x6,000; C, x10,000; D, sagittal). There is no smear layer in the dentinal tubule in the A1–D1 images of Group 1 (control) (*). The image of Group 2 (Dense BGN) shows a partially occluded dentinal tubule at 4–5 μm depth (arrow). The image of Group 3 (MBGN) shows a partially occluded dentinal tubule at 5–6 μm depth (arrow).

FESEM observation of the surfaces and longitudinal sections of the tooth samples 14 days after exposure to 6 wt.% citric acid solution showed that the concentration of particles remaining on the dentin surface differed among the groups. Group 1 (Fig 12A1–12D1) had a larger diameter dentinal tubule compared to when the samples were treated only with 1 wt.% citric acid. Group 2 (Fig 12A2–12D2) and Group 3 (Fig 12A3–12D3) had a decrease in the concentration and depth of ions blocking the tubule. Compared to those in Group 2, the particles in the tubule in Group 3 were aggregated to form a membrane-like layer that occludes the tubule.

Fig 12.

Fig 12

FESEM micrographs of the top and FESEM micrographs to examine the tubule-occluding effects in the hypersensitive tooth model after 1 min exposure to 6 wt.% citric acid (A, x2,000; B, x6,000; C, x10,000; D, sagittal). A1–D1 images of Group 1 (control) show that the diameter of the dentinal tubule increased (*). The image of Group 2 (dense BGN) shows that the concentration and depth of particles blocking the dentinal tubule have decreased. The image of Group 3 (MBGN) shows that there is a lower concentration of particles blocking the dentinal tubule and that the depth within the tubule has also decreased. Compared to those in Group 2, the particles in Group 3 aggregated and formed a membrane-like layer or box.

3.4.2. Occluding area ratio análisis

Table 2 shows the proportion of the occluded dentinal tubule before and after the 1 minute exposure to 6 wt.% citric acid in each group. An independent t-test revealed that there is no statistically significant difference after the application of 6 wt.% citric acid between the dense BGN and MBGN groups (p>0.01). After the application of 6 wt.% citric acid, the proportion of the occluded dentinal tubule decreased in each group. The degree of change was smaller in the MBGN group compared to the dense BGN group, but not to a statistically significant extent (P>0.01).

Table 2. Occluded dentinal tubule ratio analysis.
Groups Occluded area (%)
Before acid challenge
After acid challenge P-value
Control - - -
Dense BGN 75.47±4.12 55.34±8.15 0.06
MBGN 67.67±7.32 61.43±4.03 0.37
P-value 0.45 0.29

3.5. MTBS test

Fig 13 shows the mean and standard deviation of MTBS for each group. The Kruskal–Wallis test confirmed that there is no statistically significant difference among the control, dense BGN, and MBGN groups (P>0.05).

Fig 13. Microtensile bond strength of control, dense BGN, MBGN.

Fig 13

Superscript letter '*' indicates no significant difference (p>0.05).

3.6. Cytotoxicity assay

Table 3 present a graph of relative cell viability of HDPCs exposed to MBGN and dense BGN. Cell viability was analyzed at the same concentration of dense BGN and MBGN using a 2-sample t-test, and there was no statistically significant difference (P>0.05). When the concentrations of MBGN and dense BGN were varied, the Kruskal–Wallis H test showed that there were statistically significant differences in cell viability among the groups at a dense BGN concentration of 40 μg/mL and 80 μg/mL (P<0.05). However, there were no statistically significant differences in cell viability within the groups at the remaining concentrations of dense BGN and MBGN (P>0.05).

Table 3. Relative cell viability of human dental pulp cell exposed to MBGN, dens BGN at different concentration (0–320μg/mL) for 72 hours.

Concentration (μg/mL) Relative viability(%) Control 10 20 40 80 160 320
Dense BGN 100 104.04±0.78ab 95.19±3.11ab 87.16±5.48b 107.69±2.64a 96.82±3.88ab 95.20±6.62ab
MBGN 100 95.33±2.24a 90.32±8.53 a 92.92±4.26 a 108.64±0.87 a 94.14±1.90 a 91.80±2.96 a
p-value - 0.03 0.41 0.22 0.59 0.34 0.46

Same superscript lowercase letter within rows indicates no significant difference (p>0.05).

4. Discussion

DH generally occurs in the presence of external stimuli in an exposed dentinal tubule. Tubule-occluding materials have been introduced as a treatment to alleviate DH, and many recent studies have investigated the use of BGN as a tubule-occluding material. Yu et al. confirmed that BGN effectively occludes an exposed dentinal tubule [16]. Porous BG is anticipated to have a greater tubule-occluding effect, although studies that directly investigated the impact of mesopores on the tubule occlusion efficacy of BG are rare. This study aims to synthesize dense BGN, which does not have a mesoporous structure, and MBGN, which does have a mesoporous structure, and compare their dentinal tubule occlusion and bioactivity.

In this study, we synthesized MBGN and dense BGN by altering the hexadecyltrimethylammonium bromide (CTAB) content based on the sol-gel synthesis protocol. XRD data of MBGN showed a peak near 2.5°, and this suggests that MBGN is a hexagonal mesoporous structure. In contrast, dense BGN did not have a peak near 2.5°, which confirms the absence of mesopores within dense BGN (Fig 3). When the synthesized materials were analyzed with FTIR, silicate adsorption bands were observed, which suggests that silicate is a core material. In the N2 adsorption analysis, the MBGN exhibited a type IV isotherm, suggesting that there are mesopores within the material. Dense BGN exhibited a type II isotherm suggesting that the material is non-porous, which is consistent with the XRD data. BET and BJH methods used to analyze the pore characteristics of MBGN and dense BGN showed that MBGN has a larger surface area (152.40) with a large pore size compared to dense BGN and has type IV isotherm-H1 hysteresis loops, confirming that it is a material with evenly distributed pores. These structural features of dense BGN and MBGN were also confirmed in FESEM images (Fig 6), where MBGN had an irregular surface, while dense BGN had a relatively smooth surface. The irregularity of the surface of MBGN is speculated to be due to the presence of mesopores on the surface, which contains high Ca2+ and PO43- ion concentrations that would contribute to the material’s hydroxyapatite forming ability.

In this study, we prepared tablet samples and placed them in an SBF solution to determine the level of ion dissolution and hydroxyapatite deposition on the tablet. We confirmed with XRD, FTIR, and FESEM images that the SBF solution with MBGN had a greater reduction of calcium ion concentration, and only the MBGN tablets formed hydroxyapatite (Figs 8A, 9A and 10). These results are attributable to the fact that mesopores in MBGN increased the calcium ions and phosphate ions around the particles and served as an initiation site for forming hydroxyapatite crystals [19]. In the previous studies, Si-OH (silanol) group was formed after breakage of Si-O-Si bond when silica was exposed to the SBF [24]. First silicate ions in silanol groups were combined with calcium ions in SBF to form a calcium silicate. Then calcium ions in calcium silicate combined with phosphate ions in SBF to form an amorphous calcium phosphate. This amorphous calcium phosphate was transformed into crystalline apatite after Ca/P atomic ratio was increased [25]. According to Xia et al. [26], a highly ordered mesoporous structure is important for bioactivity. Silanols (Si-OH) on the surface of BGs play an important role in hydroxyapatite deposition, and MBGNs with a large surface area have more exposed Si-OH, which leads to greater hydroxyapatite deposition [24, 27, 28]. Hydroxyapatite formation was not observed in dense BGNs after soaking in SBF solution for 42 days (Figs 8B, 9B and 10), presumably because they have a smaller surface area, fewer Si-OH exposed, and the calcium and phosphate ion concentration is inadequate.

To observe the dentinal tubule-occluding effects of MBGN and dense BGN, we prepared sensitive tooth models with exposed dentinal tubules using 1 wt.% citric acid, treated them with each material, and observed the surfaces and longitudinal sections (Fig 11). FESEM images in Fig 11 showed that both dense BGN and MBGN treatment occluded the tubule in the sensitive tooth model. In terms of the occlusion pattern, MBGN had greater aggregation of particles compared to dense BGN, but there was no statistically significant difference in the dentinal tubule occluded area between the two materials. To reflect the modern dietary style characterized by frequent consumption of acidic drinks, such as carbonated drinks and fruit juices, we treated disc tooth samples with 6 wt.% citric acid and observed the surface and longitudinal sections of the samples using FESEM (Fig 12). The FESEM image of the control group showed an increased area of the opened dentinal tubule (Fig 12 A1-D1). Both the dense BGN and MBGN groups showed a reduced occluded area and depth after 6 wt.% citric acid treatment compared to that before treatment, and the degree of reduction was greater in the dense BGN group (Fig 12A2–12D2). In MBGN-treated samples, the particles aggregated and formed a membrane-like layer, and this layer is thought to have increased the resistance to citric acid (Fig 12A3–12D3). Considering the in vitro bioactivity results, the occlusion patterns of MBGN might be related to the chemical interaction between HA on MBGN particles and dentinal tubule surface. Such a trend is consistent with the findings of Chen et al. [29], where MBGN with hardening agent phosphoric acid led to better remineralized crystal formation owing to the greater bridging effect among particles compared to the BG group under equal conditions. Considering that the DH-relieving effect is proportional to the ability to occlude the opened dentinal tubule, the high bioactivity and bridging effect among particles of MBGN is anticipated to have strong DH-relieving effects by effectively occluding the tubule.

Many patients who developed tooth sensitivity as a result of dentinal tubule exposure undergo resin restoration treatment in the future. Therefore, it is imperative that the dense BGN and MBGN synthesized in this study do not have a negative impact on the bonding strength between dentin and adhesive (Fig 13). We bonded resin to the dense BGN- and MBGN-treated tooth samples using self-etch adhesive and measured MTBS values. The results showed that there were no statistically significant differences in MTBS values among the untreated control group and the dense BGN-treated and MBGN-treated groups (P>0.05). This contradicts the findings of Adebayo et al. [30] that the use of agents with tubule-occluding tendencies to treat DH hinders resin tag formation and diminishes bond strength. The self-etch adhesive used in this study was Clearfil SE bond, and in addition to forming mechanical interlocking by forming tags within the dentinal tubule, this product chemically binds to calcium exposed by acidic monomer 10-methacryloyloxydecyl dihydrogen phosphate (10-MDP) [31]. Because of this adhesion mechanism, applying dense BGN and MBGN to the tooth surface seems to have had no grave impact on the final MTBS values. This study only investigated the effects of dentinal tubule occlusion agents (dense BGN and MBGN) on the immediate MTBS of adhesive, and additional studies are needed to examine the effects of each agent during aging, such as that induced by thermocycling.

To use MBGN and dense BGN as DH treating agents, they must have low cell cytotoxicity because dental materials are supposed to contact directly with a tooth and its surrounding tissues [32]. In our study, we assessed cell viability via MTT assay by applying MBGN and dense BGN to human periodontal ligament (HPDL) cells. The MTT assay results confirmed that all concentrations of dense BGN and MBGN did not induce cell death of 20% or greater, so the materials are deemed biocompatible. However, more study is needed to investigate the cell cytotoxicity of individual components of both bioactive glasses.

This study found that both dense BGN and MBGN are effective dentinal tubule occlusion agents and that MBGN has dentin remineralization ability by facilitating hydroxyapatite deposition. Based on these facts, clinicians may consider the use of MBGN particles as a treatment option for prolonged DH. However, as this study was only conducted in vitro, additional in vivo studies are needed to evaluate the tubule occlusion durability, remineralization ability, and biocompatibility of MBGN.

5. Conclusions

In this article, we confirmed both BGN and MBGN occluded dentinal tubule mechanically. The higher bioactivity of MBGN compared with that of dense BGN arises from the structural difference, and it is anticipated to facilitate dentin remineralization by inducing hydroxyapatite deposition within the tubule and thus have higher DH-relieving effects. Therefore, BGN with mesoporous microsurface structure (MBGN) may be considered to be more effective to occlude dentinal tubule as dentin desensitizer.

Supporting information

S1 File. XRD raw data of dense BGN.

(TXT)

S2 File. XRD raw data of MBGN.

(TXT)

S3 File. Translation certificate.

(PDF)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

unfunded study.

References

  • 1.Brannstrom M, Linden LA, Arstrom A. The hydrodynamics of dental tubule and pulp fluid. A discussion of its significance in relation to dental sensitivity. Caries Res. 1967;1:310–317. 10.1159/000259530 [DOI] [PubMed] [Google Scholar]
  • 2.Ye W, Feng XP, Li R. The prevalence of dentine hypersensitivity in Chinese adults. J Oral Rehabil. 2012;39:182–187. 10.1111/j.1365-2842.2011.02248.x [DOI] [PubMed] [Google Scholar]
  • 3.Brannstrom M, Astrom A. The hydrodynamics of dentin and its possible relationship to dentinal pain. Int Dent J. 1972;22:219–227. [PubMed] [Google Scholar]
  • 4.Petersson LG. The role of fluoride in the preventive management of dentin hypersensitivity and root caries. Clin Oral Investig. 2012;17:63–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Clark D, Levin L. Non-surgical management of tooth hypersensitivity. Int Dent J. 2016;66:249–256. 10.1111/idj.12247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Greenhill JD, Pashley DH. The effects of desensitizing agents on the hydraulic conductance of human dentine in vitro. J Dent Res. 1981;60:686–698. 10.1177/00220345810600030401 [DOI] [PubMed] [Google Scholar]
  • 7.Gillam DG, Mordan NJ, Sinodinou AD, Tang JY, Knowles JC, Gibson IR. The effects of oxalate-containing products on the exposed dentine surface: an SEM investigation. J Oral Rehabil. 2001;28:1037–1044. 10.1046/j.1365-2842.2001.00775.x [DOI] [PubMed] [Google Scholar]
  • 8.Pashley DH, O’Meara JA, Kepler EE, Galloway SE, Thompson SM, Stewart FP. Dentin permeability: effects of desensitizing dentrifices in vitro. J Periodontol. 1984;55:522–525. [DOI] [PubMed] [Google Scholar]
  • 9.Zhu M, Li J, Chen B, Mei L, Yao L, Tian J, et al. The Effect of Calcium Sodium Phosphosilicate on Dentin Hypersensitivity: A Systematic Review and Meta-Analysis. PLoS One. 2015;10(11): e0140176 10.1371/journal.pone.0140176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wang Z, Sa Y, Sauro S, Chen H, Xing W, Ma X, et al. Effect of desensitising toothpastes on dentinal tubule occlusion: a dentine permeability measurement and SEM in vitro study. J Dent. 2020;38:400–410. [DOI] [PubMed] [Google Scholar]
  • 11.Wang Z, Ma X, Jiang T, Wang Y, Feng Y, Li R. The dentin tubule occlusion effects of desensitizing agents and the stability against acids and brushing challenges. Am J Dent. 2015;28:128–132. [PubMed] [Google Scholar]
  • 12.Reis C, De-Deus G, Leal F, Azevedo E, Coutinho-Filho T, Paciornik S. Strong effect on dentin after the use of high concentrations of citric acid: an assessment with co-site optical microscopy and ESEM. Dent Mater. 2008;24:1608–1615. 10.1016/j.dental.2008.03.027 [DOI] [PubMed] [Google Scholar]
  • 13.Wiegand A, Stock A, Attin R, Werner C, Attin T. Impact of the acid flow rate on dentin erosion. J Dent. 2007;35:21–27. 10.1016/j.jdent.2006.04.002 [DOI] [PubMed] [Google Scholar]
  • 14.Yu J, Yang H, Li K, Lei J, Zhou L, Huang C. A novel application of nanohydroxyapatite/mesoporous silica biocomposite on treating dentin hypersensitivity: An in vitro study. J Dent. 2016;50:21–29. 10.1016/j.jdent.2016.04.005 [DOI] [PubMed] [Google Scholar]
  • 15.Erol-Taygun M, Zheng K, Boccaccini AR. Nanoscale bioactive glasses in medical applications. Int J Appl Glas Sci. 2013;4:136–148. [Google Scholar]
  • 16.Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Enhanced Functions of Osteoblasts on Nanophase Ceramics. Biomaterials. 2000;21:1803–1810. 10.1016/s0142-9612(00)00075-2 [DOI] [PubMed] [Google Scholar]
  • 17.Ohtsuki C, Kamitakahara M, Miyazaki T. Bioactive ceramic-based materials with designed reactivity for bone tissue regeneration. J R Soc Interface. 2009;6:S349–S360. 10.1098/rsif.2008.0419.focus [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.da Cruz LPD, Hill RG, Chen X, Gillam DG. Dentine Tubule Occlusion by Novel Bioactive Glass-Based Toothpastes. Int J Dent. 2018:5701638 10.1155/2018/5701638 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Besinis A, van Noort R, Martin N. Infiltration of demineralized dentin with silica and hydroxyapatite nanoparticles. Dent Mater. 2013;28:1012–1023. [DOI] [PubMed] [Google Scholar]
  • 20.Chen WC, Kung JC, Chen CH, Hsiao YC, Shih CJ, Chien CS. Effects of bioactive glass with and without mesoporous structures ondesensitization in dentinal tubule occlusion. Appl Surf Sci. 2013;283:833–842. [Google Scholar]
  • 21.Zhu J, Liang R, Sun C, Xie L, Wang J, Leng D, et al. Effects of nanosilver and nanozinc incorporated mesoporous calcium-silicate nanoparticles on the mechanical properties of dentin. PLoS One. 2017;10(8): e0182583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zhu Y, Kaskel S. Comparison of the in vitro bioactivity and drug release property of mesoporous bioactive glasses (MBGs) and bioactive glasses (BGs) scaffolds. Microporous Mesoporous Mater. 2009;118:176–182. [Google Scholar]
  • 23.Yuan P, Liu S, Lv Y, Liu W, Ma W, Xu P. Effect of a dentifrice containing different particle sizes of hydroxyapatite on dentin tubule occlusion and aqueous Cr (VI) sorption. Int J Nanomedicine. 2019;14:5243–5256. 10.2147/IJN.S205804 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hench LL. Bioceramics: from concept to clinic. J Am Ceram Soc. 1991;74:1487–1510. [Google Scholar]
  • 25.Takadama H, Kim HM, Miyaji F, Kokubo T, Nakamura T. Journal of the Ceramic Society of Japan. 2000;108:118–121. [Google Scholar]
  • 26.Díaz A, López T, Manjarrez J, Basaldella E, Martínez-Blanes JM, Odriozola JA. Growth of hydroxyapatite in a biocompatible mesoporous ordered silica, Acta Biomater. 2006;2:173–179. 10.1016/j.actbio.2005.12.006 [DOI] [PubMed] [Google Scholar]
  • 27.Sousa A, Souza KC, Sousa EM. Mesoporous silica/apatite biocomposite: special synthesis route to control local drug delivery. Acta Biomater. 2008;4:671–679. 10.1016/j.actbio.2007.11.003 [DOI] [PubMed] [Google Scholar]
  • 28.Yan X, Yu C, Zhou X, Tang J, Zhao D. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. Angew Chem Int Ed Engl. 2004;43:5980–5984. 10.1002/anie.200460598 [DOI] [PubMed] [Google Scholar]
  • 29.Xia W, Chang J. Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system. J Control Release. 2006;110:522–530. 10.1016/j.jconrel.2005.11.002 [DOI] [PubMed] [Google Scholar]
  • 30.Chen WC, Kung JC, Chen CH, Hsiao YC, Shih CJ, Chien CS. Effects of bioactive glass with and without mesoporous structures on desensitization in dentinal tubule occlusion. Appl Surf Sci. 2013;283:833–842. [Google Scholar]
  • 31.Adebayo OA, Burrow MF, Tyas MJ. Dentine bonding after CPP-ACP paste treatment with and without conditioning. J Dent. 2008;36:1013–1024. 10.1016/j.jdent.2008.08.011 [DOI] [PubMed] [Google Scholar]
  • 32.Makkar H, Verma SK, Panda PK, Pramanik N, Jha E, Suar M. Molecular insight to size and dose-dependent cellular toxicity exhibited by a green synthesized bioceramic nanohybrid with macrophages for dental applications. Toxicol Res. 2018;7:959–969. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Hamid Reza Bakhsheshi-Rad

11 Jun 2020

PONE-D-20-07389

Effects of microsurface structure of bioactive nanoparticles on dentinal tubules as a dentin desensitizer

PLOS ONE

Dear Dr. Son,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

It has been reviewed by experts in the field and we request that you make Moderate Revisions before it is processed further. Please find your manuscript and the review reports at the following link:

Reviewer & Editor Comments

This contribution would require moderate revision before it could be reconsidered for publication in PONE. Some of my comments and questions on this manuscript are as follows:

Q1: Section including “Introduction”; “Materials and methods”; “Results”; “Discussion” and corresponding subsection is required numbering.

Q2: Some of subsections should be merged together.

Q3: “FESEM evaluation of dentinal tubule occlusion” section should be shifted to the “Materials characterizations” section.

Q4: The authors should have a consistent font size throughout the manuscript; surprisingly some part of the main text is in a BOLD type.

Q5: The author stated that “MBGNs with a large surface area have more exposed Si-OH, which leads to greater hydroxyapatite deposition [25, 26, 27]”. In this regard, the author should further highlighted the role of Si and OH ions on the acceleration of apatite deposition when MBGNs exposed to the physiological solution

Q6: I strongly recommended the author present the a schematic image regarding the preparation, and characterization of bioactive glass nanoparticle prepared by sol-gel method (Fig. 1).

Q7: The quality of the FTIR spectra of MBGN and dense BGN (Fig. 3) should be improved.

Q8: Fig. 6, Fig. 7 and Fig. 8 should be merged together and presented as Fig. 6a, b and c. The Y and X axis of all figures beside their quality should be significantly improved. ALL figures should be replotted.

Q9: The quality of Fig. 14 should be improved.

Q10: Surprisingly small reference to PLOS ONE in the literature despite the large relevant literature there. This should be improved. There are several important papers in the recent literature of PLOS ONE.

“[6,7,8,9]” should replace with “[6-9]”

“[25, 26, 27]” should replace with “[25-27]”

Please submit your revised manuscript by Jul 26 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Hamid Reza Bakhsheshi-Rad

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for providing information about the ethics approval and informed patient consent.

However, we additionally ask that you update your Methods section to specify what type of consent was given (i.e., written, verbal, etc.)

We also ask you to provide the number of the IRB-approved protocol in both the Methods and the Ethics statement, if available.

3. Please ensure that you refer to Figure 1 in your text as, if accepted, production will need this reference to link the reader to the figure.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript entitled “Effects of microsurface structure of bioactive nanoparticles on dentinal tubules as a dentin desensitizer” by Yang-Jung Choi et al is a nice submission on DH. The manuscript is acceptable with some minor changes

1. Combine line 2 and 3.

2. Abstract is too long and contain unnecessary information.

3. Experimental detail about the individual component cytotoxicity should be given.

4. Figure 1 need to be reconstructed in a visual experimental form rather than like a flow chart.

5. Figure 2A, Provide detail of peak in the picture.

6. Figure 6,7, 8 need to be made more stylish to look good for the readers.

7. Other than these minor flaws, author should also correct the English mistakes which are often present in the manuscript.

8. Recent literatures need to be cited. Some suggested one are: DOI: 10.1021/acs.chemrestox.8b00129, DOI: 10.1039/c8tx00112j

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Aug 19;15(8):e0237726. doi: 10.1371/journal.pone.0237726.r002

Author response to Decision Letter 0


19 Jul 2020

Reviewer & Editor Comments

This contribution would require moderate revision before it could be reconsidered for publication in PONE. Some of my comments and questions on this manuscript are as follows:

Q1: Section including “Introduction”; “Materials and methods”; “Results”; “Discussion” and corresponding subsection is required numbering.

A1(Answer1): We added numbering to each section and corresponding subsection.

Q2: Some of subsections should be merged together.

A2: We have merged some subsections. Please check the revised file.

In “materials and methods” section, “Synthesis of dense bioactive glass nanoparticles” and “Synthesis of mesoporous bioactive glass nanoparticles” were combined to “Synthesis of dense bioactive glass nanoparticles and mesoporous bioactive glass nanoparticles”. In “Results” section, “XRD” and “FTIR” were combined to “XRD and FTIR”.

Q3: “FESEM evaluation of dentinal tubule occlusion” section should be shifted to the “Materials characterizations” section.

A3: We thought that applying the bioactive glass on the dentinal tubules to evaluate the dentinal tubules' sealing capacity was part of the clinical application of bioactive materials. Therefore, instead of shifting to the 'materials characterization' section, it would be better to place it as a separate subtitle to highlight its clinical relevance.

Q4: The authors should have a consistent font size throughout the manuscript; surprisingly some part of the main text is in a BOLD type.

A4: We checked the whole manuscript thoroughly and corrected the wrong text type.

Q5: The author stated that “MBGNs with a large surface area have more exposed Si-OH, which leads to greater hydroxyapatite deposition [25, 26, 27]”. In this regard, the author should further highlighted the role of Si and OH ions on the acceleration of apatite deposition when MBGNs exposed to the physiological solution

A5: Thanks for pointing out. We added additional information regarding the role of Si and OH ions on the acceleration of apatite deposition when MBGN is exposed to physiological solutions. The added contents are as follows. : 1)The first silicate ion of the Si-OH group was combined with the calcium ion in the SBF solution. 2)In addition, calcium ions of calcium silicate combine with phosphate ions of SBF to form amorphous calcium phosphate. 3)This amorphous calcium phosphate was transformed into crystalline apatite. 4)MBGN with a large surface area had more exposed Si-OH and this feature accelerated the deposition of hydroxyapatite. Check the revised manuscript.

Q6: I strongly recommended the author present the a schematic image regarding the preparation, and characterization of bioactive glass nanoparticle prepared by sol-gel method (Fig. 1).

A6: We added schematic images of the fabrication and characterization of bioactive glass nanoparticles and schematic images of material methods (Fig. 1).

Q7: The quality of the FTIR spectra of MBGN and dense BGN (Fig. 3) should be improved.

A7: We replotted most figures, including FTIR spectra of MBGN and dense BGN. (Fig. 4)

Q8: Fig. 6, Fig. 7 and Fig. 8 should be merged together and presented as Fig. 6a, b and c. The Y and X axis of all figures beside their quality should be significantly improved. ALL figures should be replotted.

A8: We agree that Figures 6, 7, and 8 should be combined. We combined Figures 6, 7, and 8 into Figure 6.

Q9: The quality of Fig. 14 should be improved.

A9: We replotted Fig. 14 to improve the quality of the graph.

Q10: Surprisingly small reference to PLOS ONE in the literature despite the large relevant literature there. This should be improved. There are several important papers in the recent literature of PLOS ONE.

“[6,7,8,9]” should replace with “[6-9]”

“[25, 26, 27]” should replace with “[25-27]”

A10: We could find the recent literature of PLOS ONE about bioactive glasses and added two more references published in PLOS ONE(reference 9,21). Also, we have reformatted the reference part in the manuscript according to the above style guidelines.

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

A1: We have reformatted the manuscript according to the above style guidelines.

2. Thank you for providing information about the ethics approval and informed patient consent.

However, we additionally ask that you update your Methods section to specify what type of consent was given (i.e., written, verbal, etc.)

We also ask you to provide the number of the IRB-approved protocol in both the Methods and the Ethics statement, if available.

A2: Thank you for your concern about ethical approval and your consent for the study. Our study was a deliberation exemption study. The deliberation exemption criteria included: Researchers do not know the personally identifiable information of human-derived donors, and the results obtained through the study are not related to the donor's genetic characteristics. Therefore, we conducted a study based on donor consent exemption. We revised the information regarding the plaintiff's ethical approval and prepared and posted an ethical statement file.

3. Please ensure that you refer to Figure 1 in your text as, if accepted, production will need this reference to link the reader to the figure.

A3: We agree to offer link of the figure to the reader. Let us know if we need to revise more.

Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript entitled “Effects of microsurface structure of bioactive nanoparticles on dentinal tubules as a dentin desensitizer” by Yang-Jung Choi et al is a nice submission on DH. The manuscript is acceptable with some minor changes

1. Combine line 2 and 3.

We have combined the line 2 and 3 in the first page.

2. Abstract is too long and contain unnecessary information.

We agree that the Abstract is too long and contains unnecessary information. We have removed unnecessary experimental details and shortened the length of the Abstract.

3. Experimental detail about the individual component cytotoxicity should be given.

Thank you for the reviewer's request for experimental details of individual component cytotoxicity. In our experiments, we investigated cell viability after direct exposure to bioactive glasses according to ISO 10993-5. We have not investigated the cytotoxicity of individual components of bioactive glasses, which may be a limitation of the study. To clarify the individual component cytotoxicity of bioactive glasses, we believe more research is needed. We have added comments on the limitations of our manuscript.

4. Figure 1 need to be reconstructed in a visual experimental form rather than like a flow chart.

We have changed the type of figure from the flow chart to an experimental visual form. Please check the figure 2.

5. Figure 2A, Provide detail of peak in the picture.

We acknowledge that usually, XRD graph includes detail of peak to specify the crystal structure of materials. Since our specimen (bioactive glasses) had an amorphous structure, we concluded that it was not meant to provide detail of peak in the picture. We attached the raw data of the materials (S1, S2 file). Please check.

6. Figure 6,7, 8 need to be made more stylish to look good for the readers.

We agree that the Fig. 6, 7, 8 need to be made more stylish. Therefore, we replotted most figures. We combined Fig. 6, 7, 8 express the result of ion dissolution in the one figure (Fig 6.)

7. Other than these minor flaws, author should also correct the English mistakes which are often present in the manuscript.

We have checked the manuscript again. Also, we added a translation certificate(S3 file).

8. Recent literatures need to be cited. Some suggested one are: DOI: 10.1021/acs.chemrestox.8b00129, DOI: 10.1039/c8tx00112j

We have added a new reference at the discussion part.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Hamid Reza Bakhsheshi-Rad

3 Aug 2020

Effects of microsurface structure of bioactive nanoparticles on dentinal tubules as a dentin desensitizer

PONE-D-20-07389R1

Dear Dr. Son,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Hamid Reza Bakhsheshi-Rad

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Hamid Reza Bakhsheshi-Rad

6 Aug 2020

PONE-D-20-07389R1

Effects of microsurface structure of bioactive nanoparticles on dentinal tubules as a dentin desensitizer

Dear Dr. Son:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Hamid Reza Bakhsheshi-Rad

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. XRD raw data of dense BGN.

    (TXT)

    S2 File. XRD raw data of MBGN.

    (TXT)

    S3 File. Translation certificate.

    (PDF)

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES